Contact this trialFirst, we need to learn more about you.
Chemotherapy
Combination Immunotherapy + Chemotherapy for Pancreatic Cancer
Recruiting1 awardPhase 2
Sioux Falls, South Dakota
This trial is testing a new combination of drugs for pancreatic cancer patients who have already tried other treatments. The new combination includes aldoxorubicin, N-803, and PD-L1 t-haNK, and the goal is to find out if it is more effective and has fewer side effects than the current standard of care.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service